Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Immunol Lett. 2017 Oct 3;191:47–54. doi: 10.1016/j.imlet.2017.08.024

Figure 2.

Figure 2

Tumor-derived TGF-β directly inhibits CT26 cell proliferation in vitro.

A) The micrographs of the cell confluence of tumor cultures at day 4. B) The concentrations of tumor cells measured by hemocytometer. The data shown represent results obtained from three independent experiments. * P<0.05, **P<0.01.